These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7974026)

  • 1. [Increased levels of circulating hyaluronate in the sera of patients with rheumatoid arthritis with special reference to joint destruction].
    Yamada N; Uzuki M; Rikimaru A; Sakurai M; Sawai T
    Ryumachi; 1994 Aug; 34(4):752-60. PubMed ID: 7974026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between serum hyaluronic acid level and disease activity in early rheumatoid arthritis.
    Majeed M; McQueen F; Yeoman S; McLean L
    Ann Rheum Dis; 2004 Sep; 63(9):1166-8. PubMed ID: 15308530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SHAP-HA complex in sera from patients with rheumatoid arthritis and osteoarthritis.
    Kida D; Yoneda M; Miyaura S; Ishimaru T; Yoshida Y; Ito T; Ishiguro N; Iwata H; Kimata K
    J Rheumatol; 1999 Jun; 26(6):1230-8. PubMed ID: 10381035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of hyaluronic acid indicate the severity of joint symptoms in patients with systemic and polyarticular juvenile rheumatoid arthritis.
    Takei S; Imanaka H; Maeno N; Shigemori M; Masuda K; Hokonohara M; Miyata K
    J Rheumatol; 1996 Nov; 23(11):1956-62. PubMed ID: 8923375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N; Juillet F; Garnero P
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity.
    Emlen W; Niebur J; Flanders G; Rutledge J
    J Rheumatol; 1996 Jun; 23(6):974-8. PubMed ID: 8782125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of hyaluronic acid in the sera of women with fibromyalgia.
    Yaron I; Buskila D; Shirazi I; Neumann L; Elkayam O; Paran D; Yaron M
    J Rheumatol; 1997 Nov; 24(11):2221-4. PubMed ID: 9375887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis.
    Lard LR; Roep BO; Toes RE; Huizinga TW
    J Rheumatol; 2004 Jan; 31(1):35-9. PubMed ID: 14705216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of hyaluronan, antigenic keratan sulfate, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 change predictably in rheumatoid arthritis patients who have begun activity after a night of bed rest.
    Manicourt DH; Poilvache P; Nzeusseu A; van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 1999 Sep; 42(9):1861-9. PubMed ID: 10513800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.
    Radstake TR; Sweep FC; Welsing P; Franke B; Vermeulen SH; Geurts-Moespot A; Calandra T; Donn R; van Riel PL
    Arthritis Rheum; 2005 Oct; 52(10):3020-9. PubMed ID: 16200611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum concentration of hyaluronic acid in healthy populations and patients with rheumatoid arthritis--relationship to clinical disease activity of RA].
    Yoshinoya S; Mizoguchi Y; Hashimoto Y; Yamada A; Uchida S; Taniguchi A; Nishioka K; Miyamoto T
    Ryumachi; 1991 Aug; 31(4):381-90. PubMed ID: 1948454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum hyaluronic acid levels are elevated in arthritis patients, but normal and not associated with clinical data in patients with fibromyalgia syndrome.
    Werle E; Jäkel HP; Müller A; Fischer H; Fiehn W; Eich W
    Clin Lab; 2005; 51(1-2):11-9. PubMed ID: 15719700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
    Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis.
    van der Helm-van Mil AH; van der Kooij SM; Allaart CF; Toes RE; Huizinga TW
    Ann Rheum Dis; 2008 Jun; 67(6):769-74. PubMed ID: 17965124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative measurement of serum hyaluronic acid molecular weight in rheumatoid arthritis patients and the role of hyaluronidase.
    Sasaki Y; Uzuki M; Nohmi K; Kitagawa H; Kamataki A; Komagamine M; Murakami K; Sawai T
    Int J Rheum Dis; 2011 Oct; 14(4):313-9. PubMed ID: 22004226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of glenohumeral joint involvement in seropositive rheumatoid arthritis. A 15 year endpoint study.
    Lehtinen JT; Kaarela K; Belt EA; Kautiainen HJ; Kauppi MJ; Lehto MU
    J Rheumatol; 2000 Feb; 27(2):347-50. PubMed ID: 10685795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum hyaluronic acid and aminoterminal procollagen III peptide in inflammatory and degenerative joint diseases].
    Seibel MJ; Raimann S; Seglias J; Lautenschläger J; Müller W
    Z Rheumatol; 1988; 47(2):98-106. PubMed ID: 3388993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.